Although there has been a decline in stigma associated with HIV, as well as promising medical advancements, children and adolescents with HIV continue to experience psychological distress (Brown et al. 2000a). It is unknown how advances in antiretroviral therapy and decreasing stigma have affected suicidality. It is also unknown if stresses at specific stages of illness (e.g., diagnosis, disclosure to family) are associated with greater suicidality. The general prevalence of suicidality in adolescents and our lack of information about its timing underscore the importance of screening for suicidality throughout the course of treatment for HIV.